|
業務類別
|
Health Information Services |
|
業務概覽
|
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States. |
| 公司地址
| 1540 Broadway, 24th Floor, New York, NY, USA, 10036 |
| 電話號碼
| +1 212 295-5800 |
| 傳真號碼
| +1 212 295-5801 |
| 公司網頁
| https://www.schrodinger.com |
| 員工數量
| 850 |
| Mr. Kenneth Patrick Lorton |
Chief Operating Officer, Software, Executive Vice President and Chief Technology Officer |
美元 460.02K |
24/04/2025 |
| Ms. Yvonne Tran |
Executive Vice President, Chief Legal Officer and Chief People Officer |
-- |
24/04/2025 |
| Dr. Karen Akinsanya, PhD |
President, R&D Therapeutics |
美元 562.64K |
24/04/2025 |
| Dr. Robert Abel, PhD |
Executive Vice President, Chief Computational Scientist |
美元 460.02K |
24/04/2025 |
| Dr. Ramy Farid, PhD |
Director, Chief Executive Officer and President |
美元 704.08K |
25/02/2026 |
| Dr. Margaret Dugan, M.D. |
Chief Medical Officer |
-- |
24/04/2025 |
| Mr. Richie Jain |
Executive Vice President, Chief Financial Officer and Treasurer |
-- |
25/02/2026 |
| Ms. Therese Abrams |
Principal Accounting Officer, Vice President and Corporate Controller |
-- |
12/03/2026 |
|
|
| Ms. Bridget A. van Kralingen |
Director |
25/02/2026 |
| Ms. Nancy A. Thornberry |
Independent Director |
25/02/2026 |
| Dr. Richard A. Friesner, PhD |
Director |
25/02/2026 |
| Dr. Rosana Kapeller-Libermann, M.D.,PhD |
Independent Director |
25/02/2026 |
| Dr. Ramy Farid, PhD |
Director, Chief Executive Officer and President |
25/02/2026 |
| Dr. Jeffrey A. Chodakewitz, M.D. |
Independent Director |
25/02/2026 |
| Mr. Michael M. Lynton |
Chairman of the Board |
25/02/2026 |
| Mr. Gary L. Sender |
Independent Director |
25/02/2026 |
| Mr. Gary L. Ginsberg |
Independent Director |
25/02/2026 |
| Mr. Arun Oberoi |
Independent Director |
25/02/2026 |
|
|
|
|
